J D Teale

2.2k total citations
51 papers, 1.6k citations indexed

About

J D Teale is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, J D Teale has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in J D Teale's work include Growth Hormone and Insulin-like Growth Factors (18 papers), Metabolism, Diabetes, and Cancer (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). J D Teale is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (18 papers), Metabolism, Diabetes, and Cancer (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). J D Teale collaborates with scholars based in United Kingdom, Singapore and United States. J D Teale's co-authors include V. Marks, Gwen Wark, Jeremy Millar, Laurence J. King, I E Smith, Rousseau Gama, John McKnight, C. Bolton, J.C. Reubi and P. A. Trott and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

J D Teale

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J D Teale United Kingdom 26 735 492 342 279 229 51 1.6k
Pascale de Lonlay France 26 1.0k 1.4× 685 1.4× 216 0.6× 132 0.5× 92 0.4× 71 2.0k
Henry Johansson Sweden 23 450 0.6× 229 0.5× 342 1.0× 421 1.5× 36 0.2× 75 1.5k
Lars Steen Sweden 23 343 0.5× 1.8k 3.7× 380 1.1× 292 1.0× 140 0.6× 52 2.4k
R. Gasser Austria 23 450 0.6× 158 0.3× 230 0.7× 245 0.9× 49 0.2× 57 1.2k
Michael M. Ritter Germany 18 551 0.7× 206 0.4× 259 0.8× 124 0.4× 34 0.1× 43 1.2k
Stefan K. Nilsson Sweden 21 422 0.6× 554 1.1× 366 1.1× 90 0.3× 79 0.3× 39 1.9k
J. Breza Slovakia 25 525 0.7× 405 0.8× 84 0.2× 166 0.6× 167 0.7× 102 1.8k
Joanna Kłubo-Gwieździńska United States 23 1.0k 1.4× 591 1.2× 205 0.6× 370 1.3× 29 0.1× 89 1.9k
Indraneel Banerjee United Kingdom 23 1.3k 1.8× 454 0.9× 156 0.5× 201 0.7× 38 0.2× 110 1.9k
S. Jacobs United States 23 116 0.2× 152 0.3× 193 0.6× 233 0.8× 109 0.5× 46 1.3k

Countries citing papers authored by J D Teale

Since Specialization
Citations

This map shows the geographic impact of J D Teale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J D Teale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J D Teale more than expected).

Fields of papers citing papers by J D Teale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J D Teale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J D Teale. The network helps show where J D Teale may publish in the future.

Co-authorship network of co-authors of J D Teale

This figure shows the co-authorship network connecting the top 25 collaborators of J D Teale. A scholar is included among the top collaborators of J D Teale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J D Teale. J D Teale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teale, J D & Gwen Wark. (2004). The effectiveness of different treatment options for non‐islet cell tumour hypoglycaemia. Clinical Endocrinology. 60(4). 457–460. 74 indexed citations
2.
Teale, J D, Gwen Wark, & V. Marks. (2002). The biochemical investigation of cases of hypoglycaemia: an assessment of the clinical effectiveness of analytical services. Journal of Clinical Pathology. 55(7). 503–507. 2 indexed citations
3.
Seckl, Michael J., Paul Mulholland, Anne E. Bishop, et al.. (1999). Hypoglycemia Due to an Insulin-Secreting Small-Cell Carcinoma of the Cervix. New England Journal of Medicine. 341(10). 733–736. 49 indexed citations
4.
Marks, V. & J D Teale. (1999). HYPOGLYCEMIA: FACTITIOUS AND FELONIOUS. Endocrinology and Metabolism Clinics of North America. 28(3). 579–601. 40 indexed citations
5.
Teale, J D & V. Marks. (1998). Glucocorticoid therapy suppresses abnormal secretion of big IGF‐II by non‐islet cell tumours inducing hypoglycaemia (NICTH). Clinical Endocrinology. 49(4). 491–498. 78 indexed citations
6.
Holt, Richard I. G., et al.. (1998). Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Growth Hormone & IGF Research. 8(6). 447–454. 15 indexed citations
7.
Gama, Rousseau, J D Teale, Jeremy Wright, Gordon A. Ferns, & V. Marks. (1997). Hyperproinsulinaemia in Acromegaly: Evidence for Abnormal Pancreatic β-Cell Function?. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(6). 627–631. 4 indexed citations
8.
Kicman, Andrew T., J P Miell, J D Teale, et al.. (1997). Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH. Clinical Endocrinology. 47(1). 43–50. 52 indexed citations
9.
Perros, Petros, A. John Simpson, J. A. Innes, J D Teale, & John McKnight. (1996). Non‐islet cell tumour‐associated hypoglycaemia: 111In‐octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clinical Endocrinology. 44(6). 727–731. 50 indexed citations
10.
Hunter, Steven, William H. Daughaday, Michael E. Callender, et al.. (1994). A case of hepatoma associated with hypoglycaemia and overproduction of IGF‐II (E‐21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clinical Endocrinology. 41(3). 397–401. 32 indexed citations
11.
12.
Teale, J D, Werner Blum, & V. Marks. (1992). Alleviation of Non-Islet Cell Tumour Hypoglycaemia by Growth Hormone Therapy is Associated with Changes in IGF Binding Protein-3. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 29(3). 314–323. 37 indexed citations
13.
Marks, V. & J D Teale. (1991). Tumours producing hypoglycaemia. Diabetes/Metabolism Reviews. 7(2). 79–91. 51 indexed citations
14.
Smith, IE, et al.. (1991). Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer. British Journal of Cancer. 64(3). 451–456. 69 indexed citations
15.
Gama, Rousseau, J D Teale, & V. Marks. (1990). The effect of synthetic very low calorie diets on the GH-IGF-1 axis in obese subjects. Clinica Chimica Acta. 188(1). 31–38. 25 indexed citations
16.
Pringle, P J, Peter C. Hindmarsh, L. Di Silvio, et al.. (1989). The measurement and effect of growth hormone in the presence of growth hormone-binding antibodies. Journal of Endocrinology. 121(1). 193–199. 4 indexed citations
17.
Saini, J., Jane B. Morgan, J D Teale, & I Z Kovar. (1989). Insulin-Like Growth Factor-I in the Parenterally Fed Low Birth Weight Infant. Annals of Nutrition and Metabolism. 33(2). 88–91. 2 indexed citations
18.
Gibbs, N. M., et al.. (1987). Thyroid dysfunction in institutionalised Down's syndrome adults. Psychological Medicine. 17(2). 387–392. 25 indexed citations
19.
Bourne, Rachel C., et al.. (1978). A simple radioimmunoassay for plasma diazepam and its application to single dose studies in man [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 371P–371P. 2 indexed citations
20.
Braithwaite, R A, et al.. (1977). Unusual case of tetrahydrocannabinol intoxication confirmed by radioimmunoassay.. BMJ. 2(6080). 166.1–166. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascale de Lonlay Breakdown of academic impact, for papers by Henry Johansson Breakdown of academic impact, for papers by Lars Steen Breakdown of academic impact, for papers by R. Gasser Breakdown of academic impact, for papers by Michael M. Ritter Breakdown of academic impact, for papers by Stefan K. Nilsson Breakdown of academic impact, for papers by J. Breza Breakdown of academic impact, for papers by Joanna Kłubo-Gwieździńska Breakdown of academic impact, for papers by Indraneel Banerjee Breakdown of academic impact, for papers by S. Jacobs
Rankless by CCL
2026